Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
DECT examination: DECT examinations will be performed using a 192-slice CT scanner (SOMATOM, Force, Siemens, Forchheim, Germany).
mpMRI examination: The examinations were conducted on a 3-T MR scanner (MAGNETOM Skyra; Siemens Healthcare, Erlangen, Germany).
Study summary
Accurate preoperative staging of gastric cancer is of major importance for guiding therapeutic decision-making, preventing both under- and over-treatment. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and dual-energy computed tomography (DECT) in gastric cancer.
Eligibility
Primary outcome measure(s)
- Diagnostic performance of DECT and mpMRI in tumor staging assessment — 2 years
Accuracy for both imaging techniques in the prediction of tumor staging. - Diagnostic performance of DECT and mpMRI in tumor restaging assessment — 2 years
Accuracy for both imaging techniques in the prediction of tumor restaging.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Yu-Dong Zhang | Nanjing | China | Recruiting |
More The First Affiliated Hospital with Nanjing Medical University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05508126 on ClinicalTrials.gov ↗ ← All trials in China